|
SMAD2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.46479511748043E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.42950004558651E-09 |
| Normal-vs-Stage2 |
1.80197999999354E-05 |
| Normal-vs-Stage3 |
1.4082000010518E-09 |
| Normal-vs-Stage4 |
3.14739999951463E-07 |
| Stage1-vs-Stage2 |
9.924200E-01 |
| Stage1-vs-Stage3 |
2.815000E-01 |
| Stage1-vs-Stage4 |
6.599600E-01 |
| Stage2-vs-Stage3 |
4.553200E-01 |
| Stage2-vs-Stage4 |
7.127400E-01 |
| Stage3-vs-Stage4 |
7.121600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.97340033203375E-10 |
| Normal-vs-AfricanAmerican |
2.622600E-03 |
| Normal-vs-Asian |
3.63270000003357E-06 |
| Caucasian-vs-AfricanAmerican |
3.126800E-01 |
| Caucasian-vs-Asian |
9.146400E-01 |
| AfricanAmerican-vs-Asian |
3.977800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.3595999598669E-09 |
| Normal-vs-Female |
2.39099962051625E-10 |
| Male-vs-Female |
6.096600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.90979999779162E-08 |
| Normal-vs-Age(41-60Yrs) |
3.30440008688981E-10 |
| Normal-vs-Age(61-80Yrs) |
1.81280002120587E-09 |
| Normal-vs-Age(81-100Yrs) |
5.142100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.294400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.598400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.479800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.087600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.149800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.647400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.990400E-01 |
| Classical-VS-Follicular |
2.174000E-02 |
| Classical-VS-Other |
5.422600E-01 |
| Classical-VS-Normal |
5.5708000434862E-09 |
| Tall-VS-Follicular |
3.973800E-01 |
| Tall-VS-Other |
7.316000E-01 |
| Tall-VS-Normal |
6.05470000000219E-05 |
| Follicular-VS-Other |
8.780000E-01 |
| Follicular-VS-Normal |
8.11909994791193E-09 |
| Other-VS-Normal |
1.217920E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.50030013254832E-11 |
| Normal-vs-N1 |
3.48100000047147E-07 |
| N0-vs-N1 |
7.165400E-01 |
|
|
